KRT8 Antibody / Cytokeratin 8

Contact us
NSJ Bioreagents
Product Code: NSJ-V9038
Product Group: Primary Antibodies
Supplier: NSJ Bioreagents
CodeSizePrice
NSJ-V9038-20UG20 ug£264.00
Quantity:
NSJ-V9038-100UG100 ug£534.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: Mouse IgG1, kappa
Antibody Clonality: Monoclonal
Antibody Clone: SPM538
Regulatory Status: RUO
Target Species: Human
Applications:
  • Fluorescence-activated cell sorting (FACS)
  • Immunofluorescence (IF)
  • Immunohistochemistry- Paraffin Embedded (IHC-P)
Storage:
Store the Cytokeratin 8 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Images

1 / 4
Immunofluorescent staining of fixed human MCF7 cells with Cytokeratin 8 antibody (clone SPM538, green) and Reddot nuclear stain (red).
2 / 4
IHC: Formalin-fixed, paraffin-embedded human lung carcinoma stained with Cytokeratin 8 antibody (clone SPM538).
3 / 4
Flow cytometry testing of MeOH fixed human HeLa cells with Cytokeratin 8 antibody (clone SPM538); Red=isotype control, Blue= Cytokeratin 8 antibody.
4 / 4
SDS-PAGE analysis of purified, BSA-free Cytokeratin 8 antibody (clone SPM538) as confirmation of integrity and purity.
❮❯

Immunofluorescent staining of fixed human MCF7 cells with Cytokeratin 8 antibody (clone SPM538, green) and Reddot nuclear stain (red).
IHC: Formalin-fixed, paraffin-embedded human lung carcinoma stained with Cytokeratin 8 antibody (clone SPM538).
Flow cytometry testing of MeOH fixed human HeLa cells with Cytokeratin 8 antibody (clone SPM538); Red=isotype control, Blue= Cytokeratin 8 antibody.
SDS-PAGE analysis of purified, BSA-free Cytokeratin 8 antibody (clone SPM538) as confirmation of integrity and purity.

Documents

Further Information

Application Details :
Flow cytometry: 1-2ug/million cells,Immunofluorescence: 1-2ug/ml,Immunohistochemistry (FFPE): 1-2ug/ml for 30 min at RT
Application Note:
Optimal dilution of the antibody should be determined by the researcher.
Description:
Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ('ring-like, perinuclear') from ductal ('peripheral-predominant') carcinoma of the breast.
Format :
Purified
Formulation :
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide
Immunogen:
A cytoskeleton preparation containing keratin 8 was used as the immunogen for this Cytokeratin 8 antibody.
Limitation:
This Cytokeratin 8 antibody is available for research use only.
Localization:
Cytoplasmic
Purity:
Protein G affinity chromatography
Species Reactivity :
Human
Uniprot #:
P05787